Pharmaceuticals News at Healthcare Opportunity

Asymmetry Capital Management buys share for $2.82M in CVS Health Corp.

Mateen Dalal Dec 10, 2018 Pharmaceuticals

San Francisco’s asset management firm, Asymmetry Capital Management L.P. has recently acquired 35,870 shares of retail pharmacy and health care giant, CVS Health Corp. in the Q3 for approximately …

Roche’s Tecentriq Regimen receives U.S. FDA approval to treat NSCLC

Mateen Dalal Dec 9, 2018 Pharmaceuticals

Swiss multinational healthcare giant Roche has reportedly announced that it has received the approval by the United States Food and Drug Administration (U.S. FDA) for its Tecentriq atezolizumab regimen. …

Tychan starts Phase I trials of its first-in-class Yellow Fever drug

Mateen Dalal Dec 8, 2018 Pharmaceuticals

Singapore based biotech firm Tychan has reportedly announced that its first-in-class candidate drug for treating Yellow Fever has obtained an investigatory new drug (IND) regulatory approval from Singapore’s Health …

Scientus Pharma gets patent for Decarboxylated Cannabis Resins Method

Mateen Dalal Dec 6, 2018 Pharmaceuticals

Canada-based biopharmaceutical firm HydRx Farms Ltd. (operating as Scientus Pharma) has reportedly announced to have received the U.S. Patent Number 10,143,706 from the United States Patent and Trademark Office. …

Category: Pharmaceuticals